Donald A. Denkhaus - 03 Aug 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Donald A. Denkhaus
Issuer symbol
CPRX
Transactions as of
03 Aug 2023
Net transactions value
+$67,800
Form type
4
Filing time
04 Aug 2023, 17:00:27 UTC
Previous filing
17 Feb 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $67,800 +60,000 +18% $1.13 393,000 03 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -60,000 -23% $0.000000 200,500 03 Aug 2023 Common Stock 60,000 $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vested in three equal tranches on January 3, 2018, 2019 and 2020.